Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/a-clinician-s-guide-to-pemphigus-vulgaris-clinical-research-mSHWBjG4vM
References (33)
-
M. Saha, B. Bhogal, M. Black, D. Cooper, Robert Vaughan, Richard Groves (2014)
Prognostic factors in pemphigus vulgaris and pemphigus foliaceusBritish Journal of Dermatology, 170
-
M. Valikhani, S. Kavusi, C. Chams‐Davatchi, Z. Hallaji, N. Esmaili, N. Ghandi, F. Farahani, V. Lajevardi (2008)
Impact of smoking on pemphigusInternational Journal of Dermatology, 47
-
M. Pfütze, R. Eming, A. Kneisel, U. Kuhlmann, J. Hoyer, M. Hertl (2008)
Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or RituximabDermatology, 218
-
A. Nagel, M. Hertl, R. Eming (2009)
B-cell-directed therapy for inflammatory skin diseases.The Journal of investigative dermatology, 129 2
-
C. Sitaru, D. Zillikens (2005)
Mechanisms of blister induction by autoantibodiesExperimental Dermatology, 14
-
M. Valikhani, S. Kavusi, C. Chams‐Davatchi, M. Daneshpazhooh, M. Barzegari, M. Ghiasi, R. Abedini (2007)
Pemphigus and associated environmental factors: a case–control studyClinical and Experimental Dermatology, 32
-
M. Seidenbaum, M. David, M. Sandbank (1988)
The Course and Prognosis of PemphigusInternational Journal of Dermatology, 27
-
P. Carson, A. Hameed, Abdul Ahmed (1996)
Influence of treatment on the clinical course of pemphigus vulgaris.Journal of the American Academy of Dermatology, 34 4
-
J. Savin (1981)
Some factors affecting prognosis in pemphigus vulgaris and pemphigoidBritish Journal of Dermatology, 104
-
S. Venugopal, D. Murrell (2011)
Diagnosis and clinical features of pemphigus vulgaris.Dermatologic clinics, 29 3
-
M. Arin, N. Hunzelmann (2005)
Anti-B- cell-directed immunotherapy (rituximab) in the treatment of refractory pemphigus--an update.European journal of dermatology : EJD, 15 4
-
A. Herbst, J. Bystryn (2000)
Patterns of remission in pemphigus vulgaris.Journal of the American Academy of Dermatology, 42 3
-
A. Patsatsi, A. Kyriakou, A. Giannakou, A. Pavlitou-Tsiontsi, A. Lambropoulos, D. Sotiriadis (2014)
Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in Pemphigus Patients Measured by Area Index and Intensity Score.Acta dermato-venereologica, 94 2
-
S. Kavusi, M. Daneshpazhooh, F. Farahani, R. Abedini, V. Lajevardi, C. Chams‐Davatchi (2008)
Outcome of pemphigus vulgarisJournal of the European Academy of Dermatology and Venereology, 22
-
C. Chams‐Davatchi, M. Valikhani, M. Daneshpazhooh, N. Esmaili, K. Balighi, Z. Hallaji, M. Barzegari, M. Akhiani, Z. Ghodsi, H. Mortazavi, Z. Naraghi (2005)
Pemphigus: Analysis of 1209 casesInternational Journal of Dermatology, 44
-
E. Schmidt, M. Goebeler, D. Zillikens (2009)
Rituximab in Severe PemphigusAnnals of the New York Academy of Sciences, 1173
-
S. Mihai, C. Sitaru (2007)
Immunopathology and molecular diagnosis of autoimmune bullous diseasesJournal of Cellular and Molecular Medicine, 11
-
K. Harman, M. Gratian, B. Bhogal, S. Challacombe, M. Black (2000)
A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotypeBritish Journal of Dermatology, 143
-
K. James, D. Culton, L. Diaz (2011)
Diagnosis and clinical features of pemphigus foliaceus.Dermatologic clinics, 29 3
-
N. Meyer, L. Miséry (2010)
Geoepidemiologic considerations of auto-immune pemphigus.Autoimmunity reviews, 9 5
-
C. Chams‐Davatchi, Z. Rahbar, M. Daneshpazhooh, Seyed Mortazavizadeh, M. Akhyani, N. Esmaili, K. Balighi (2013)
Pemphigus vulgaris activity score and assessment of convergent validity.Acta medica Iranica, 51 4
-
Pascal Joly, N. Litrowski (2011)
Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis).Clinics in dermatology, 29 4
-
P. Joly, H. Mouquet, J. Roujeau, M. D’Incan, D. Gilbert, S. Jacquot, M. Gougeon, C. Bédane, R. Mûller, B. Dréno, M. Doutre, E. Delaporte, C. Pauwels, N. Franck, F. Caux, C. Picard, E. Tancrède‐Bohin, P. Bernard, F. Tron, M. Hertl, P. Musette (2007)
A single cycle of rituximab for the treatment of severe pemphigus.The New England journal of medicine, 357 6
-
C. Chams‐Davatchi (2011)
Prevalence and treatment of pemphigus in Iran.Dermatologic clinics, 29 4
-
W. Ramos, Gina Chacon, C. Galarza, E. Gutierrez, M. Smith, A. Ortega‐Loayza (2012)
Endemic pemphigus in the Peruvian Amazon: epidemiology and risk factors for the development of complications during treatment*Anais brasileiros de dermatologia, 87
-
S. Beissert, D. Mimouni, A. Kanwar, N. Solomons, V. Kalia, G. Anhalt (2010)
Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial.The Journal of investigative dermatology, 130 8
-
Jessica Mehta, Ann Martin (2000)
A case of pemphigus vulgaris improved by cigarette smoking.Archives of dermatology, 136 1
-
A. Kneisel, M. Hertl (2011)
Autoimmune bullous skin diseases. Part 1: Clinical manifestationsJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 9
-
M. Daneshpazhooh, C. Chams‐Davatchi, P. Payandemehr, S. Nassiri, M. Valikhani, Zahra Safai-Naraghi (2012)
Spectrum of autoimmune bullous diseases in Iran: a 10‐year reviewInternational Journal of Dermatology, 51
-
M. Hertl (2000)
Humoral and Cellular Autoimmunity in Autoimmune Bullous Skin DisordersInternational Archives of Allergy and Immunology, 122
-
D. Murrell, Sarah Dick, Abdul Ahmed, M. Amagai, M. Barnadas, L. Borradori, J. Bystryn, G. Cianchini, L. Diaz, D. Fivenson, R. Hall, K. Harman, T. Hashimoto, M. Hertl, N. Hunzelmann, P. Iranzo, P. Joly, M. Jonkman, Y. Kitajima, N. Korman, L. Martin, D. Mimouni, A. Pandya, A. Payne, David Rubenstein, H. Shimizu, A. Sinha, D. Sirois, D. Zillikens, V. Werth (2008)
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus.Journal of the American Academy of Dermatology, 58 6
-
A. Nagel, A. Lang, D. Engel, E. Podstawa, N. Hunzelmann, O. Pità, L. Borradori, W. Uter, M. Hertl (2010)
Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3.Clinical immunology, 134 3
-
S. Brenner, Y. Wohl (2007)
A survey of sex differences in 249 pemphigus patients and possible explanations.Skinmed, 6 4
- Publisher
- Springer International Publishing
- Copyright
- © Springer International Publishing AG 2018
- ISBN
- 978-3-319-67758-3
- Pages
- 53 –58
- DOI
- 10.1007/978-3-319-67759-0_10
- Publisher site
- See Chapter on Publisher Site
Abstract
[Pemphigus vulgaris is a severe autoimmune disease diagnosed by painful erosions and extensive blistering of the skin and mucous membranes. Autoantibodies against epicutaneous antigens cause the blisters and erosions in pemphigus vulgaris. Among them, antigens such as desmoglein 1 and 3 are of particular importance. The aim of the author’s study was to determine the relationship between the levels of autoantibodies against desmoglein 1 and 3, using the enzyme-linked immunosorbent assay (ELISA) method in patients newly diagnosed with pemphigus vulgaris, and timeline of the disease among the patients hospitalized in Razi Hospital, Tehran, Iran, during 2013–2014.]
Published: Nov 27, 2017
Keywords: Pemphigus vulgaris; Pemphigus Disease Area Index (PDAI); Desmoglein; Anti-desmoglein; Autoantibodies; Remission; Enzyme-linked immunosorbent assay (ELISA)